• Je něco špatně v tomto záznamu ?

Disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic in March-October 2020: An exploratory analysis

M. Modrák, PC. Bürkner, T. Sieger, T. Slisz, M. Vašáková, G. Mesežnikov, LF. Casas-Mendez, J. Vajter, J. Táborský, V. Kubricht, D. Suk, J. Horejsek, M. Jedlička, A. Mifková, A. Jaroš, M. Kubiska, J. Váchalová, R. Šín, M. Veverková, Z. Pospíšil,...

. 2021 ; 16 (10) : e0245103. [pub] 20211006

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003497

We collected a multi-centric retrospective dataset of patients (N = 213) who were admitted to ten hospitals in Czech Republic and tested positive for SARS-CoV-2 during the early phases of the pandemic in March-October 2020. The dataset contains baseline patient characteristics, breathing support required, pharmacological treatment received and multiple markers on daily resolution. Patients in the dataset were treated with hydroxychloroquine (N = 108), azithromycin (N = 72), favipiravir (N = 9), convalescent plasma (N = 7), dexamethasone (N = 4) and remdesivir (N = 3), often in combination. To explore association between treatments and patient outcomes we performed multiverse analysis, observing how the conclusions change between defensible choices of statistical model, predictors included in the model and other analytical degrees of freedom. Weak evidence to constrain the potential efficacy of azithromycin and favipiravir can be extracted from the data. Additionally, we performed external validation of several proposed prognostic models for Covid-19 severity showing that they mostly perform unsatisfactorily on our dataset.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003497
003      
CZ-PrNML
005      
20240206092932.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0245103 $2 doi
035    __
$a (PubMed)34613965
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Modrák, Martin $u Bioinformatics Core Facility, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic $7 xx0313530
245    10
$a Disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic in March-October 2020: An exploratory analysis / $c M. Modrák, PC. Bürkner, T. Sieger, T. Slisz, M. Vašáková, G. Mesežnikov, LF. Casas-Mendez, J. Vajter, J. Táborský, V. Kubricht, D. Suk, J. Horejsek, M. Jedlička, A. Mifková, A. Jaroš, M. Kubiska, J. Váchalová, R. Šín, M. Veverková, Z. Pospíšil, J. Vohryzková, R. Pokrievková, K. Hrušák, K. Christozova, V. Leos-Barajas, K. Fišer, T. Hyánek
520    9_
$a We collected a multi-centric retrospective dataset of patients (N = 213) who were admitted to ten hospitals in Czech Republic and tested positive for SARS-CoV-2 during the early phases of the pandemic in March-October 2020. The dataset contains baseline patient characteristics, breathing support required, pharmacological treatment received and multiple markers on daily resolution. Patients in the dataset were treated with hydroxychloroquine (N = 108), azithromycin (N = 72), favipiravir (N = 9), convalescent plasma (N = 7), dexamethasone (N = 4) and remdesivir (N = 3), often in combination. To explore association between treatments and patient outcomes we performed multiverse analysis, observing how the conclusions change between defensible choices of statistical model, predictors included in the model and other analytical degrees of freedom. Weak evidence to constrain the potential efficacy of azithromycin and favipiravir can be extracted from the data. Additionally, we performed external validation of several proposed prognostic models for Covid-19 severity showing that they mostly perform unsatisfactorily on our dataset.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a COVID-19 $x epidemiologie $x patologie $x terapie $7 D000086382
650    12
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a statistické modely $7 D015233
650    _2
$a farmakoterapie COVID-19 $7 D000093485
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bürkner, Paul-Christian $u Cluster of Excellence SimTech, University of Stuttgart, Stuttgart, Deutschland, Germany
700    1_
$a Sieger, Tomáš $u Dept. of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
700    1_
$a Slisz, Tomáš $u Department of Respiratory Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Vašáková, Martina $u Department of Respiratory Medicine, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Mesežnikov, Grigorij $u Motol University Hospital, Prague, Czech Republic
700    1_
$a Casas-Mendez, Luis Fernando $u Motol University Hospital, Prague, Czech Republic
700    1_
$a Vajter, Jaromír $u Motol University Hospital, Prague, Czech Republic
700    1_
$a Táborský, Jan $u AGEL Hospital Nový Jičín, Nový Jičín, Czech Republic
700    1_
$a Kubricht, Viktor $u Kralovské Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Suk, Daniel $u General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Horejsek, Jan $u General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Jedlička, Martin $u Military Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Mifková, Adriana $u Military Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Jaroš, Adam $u Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Kubiska, Miroslav $u Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen, Czech Republic
700    1_
$a Váchalová, Jana $u Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen, Czech Republic
700    1_
$a Šín, Robin $u Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen, Czech Republic
700    1_
$a Veverková, Markéta $u Hořovice Hospital, Hořovice, Czech Republic
700    1_
$a Pospíšil, Zbyšek $u Třebíč Hospital, Třebíč, Czech Republic
700    1_
$a Vohryzková, Julie $u 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Pokrievková, Rebeka $u 3rd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Hrušák, Kristián $u 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Christozova, Kristína $u 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Leos-Barajas, Vianey $u Department of Statistical Sciences, University of Toronto, Toronto, Canada
700    1_
$a Fišer, Karel $u Department of Bioinformatics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Hyánek, Tomáš $u Na Homolce Hospital, Prague, Czech Republic
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 16, č. 10 (2021), s. e0245103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34613965 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20240206092929 $b ABA008
999    __
$a ok $b bmc $g 1751064 $s 1154646
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 16 $c 10 $d e0245103 $e 20211006 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace